Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity.
- DOI
- 10.1016/j.medj.2026.101149
- Published
- 2026 Jul 10
- Container
- Med (New York, N.Y.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.medj.2026.101149,
title = {Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity.},
author = {Lopez-Lago MA and Taleb M and Ningoo M and Okada T and Li X and Lee HS and Burt BM and Offin M and Chintala NK and Adusumilli PS},
year = {2026},
journal = {Med (New York, N.Y.)},
doi = {10.1016/j.medj.2026.101149},
url = {https://doi.org/10.1016/j.medj.2026.101149}
}RIS
TY - JOUR TI - Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity. AU - Lopez-Lago MA AU - Taleb M AU - Ningoo M AU - Okada T AU - Li X AU - Lee HS AU - Burt BM AU - Offin M AU - Chintala NK AU - Adusumilli PS PY - 2026 JO - Med (New York, N.Y.) DO - 10.1016/j.medj.2026.101149 UR - https://doi.org/10.1016/j.medj.2026.101149 ER -
APA
MA, L., M, T., M, N., T, O., X, L., HS, L., BM, B., M, O., NK, C., & PS, A. (2026). Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity.. Med (New York, N.Y.). https://doi.org/10.1016/j.medj.2026.101149
Source records
- pubmed · retrieved 2026-09-26T11:16:42.402Z